Ameriprise’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$711K Sell
41,856
-104
-0.2% -$1.77K ﹤0.01% 3438
2025
Q4
$788K Buy
41,960
+2,790
+7% +$42.1K ﹤0.01% 3447
2025
Q3
$501K Sell
39,170
-7,233
-16% -$108K ﹤0.01% 3625
2025
Q2
$780K Buy
46,403
+9,599
+26% +$130K ﹤0.01% 3366
2025
Q1
$471K Buy
36,804
+2,252
+7% +$36.1K ﹤0.01% 3512
2024
Q4
$610K Buy
34,552
+16,643
+93% +$316K ﹤0.01% 3445
2024
Q3
$409K Buy
+17,909
New +$405K ﹤0.01% 3556
2024
Q2
Sell
-51,604
Closed -$2.04M 3916
2024
Q1
$2.04M Hold
51,604
﹤0.01% 2864
2023
Q4
$2.04M Buy
51,604
+9,572
+23% +$401K ﹤0.01% 2860
2023
Q3
$1.87M Sell
42,032
-1,236
-3% -$53.9K ﹤0.01% 2850
2023
Q2
$1.88M Sell
43,268
-11,426
-21% -$502K ﹤0.01% 2902
2023
Q1
$2.38M Buy
54,694
+14,503
+36% +$640K ﹤0.01% 2759
2022
Q4
$1.5M Buy
40,191
+148
+0.4% +$5.72K ﹤0.01% 2931
2022
Q3
$1.59M Sell
40,043
-90
-0.2% -$3.33K ﹤0.01% 2879
2022
Q2
$1.53M Buy
40,133
+2,715
+7% +$98.2K ﹤0.01% 2927
2022
Q1
$1.48M Sell
37,418
-289,693
-89% -$11.3M ﹤0.01% 3043
2021
Q4
$13.6M Hold
327,111
﹤0.01% 1721
2021
Q3
$13.8M Buy
327,111
+1,850
+0.6% +$93.2K ﹤0.01% 1579
2021
Q2
$14.9M Hold
325,261
﹤0.01% 1582
2021
Q1
$15.2M Sell
325,261
-21,433
-6% -$1.04M 0.01% 1546
2020
Q4
$14.8M Sell
346,694
-9,434
-3% -$484K 0.01% 1445
2020
Q3
$17.5M Sell
356,128
-1,094
-0.3% -$60.6K 0.01% 1157
2020
Q2
$20.8M Buy
357,222
+176
+0% +$9.3K 0.01% 1032
2020
Q1
$16.2M Buy
357,046
+107,146
+43% +$6.44M 0.01% 1071
2019
Q4
$16.5M Sell
249,900
-75,256
-23% -$4.6M 0.01% 1331
2019
Q3
$18.8M Sell
325,156
-38,598
-11% -$2.39M 0.01% 1184
2019
Q2
$20.9M Buy
363,754
+4,869
+1% +$225K 0.01% 1129
2019
Q1
$13.9M Buy
358,885
+289,035
+414% +$11.3M 0.01% 1426
2018
Q4
$2.67M Buy
69,850
+12,500
+22% +$480K ﹤0.01% 2508
2018
Q3
$2.21M Buy
57,350
+6,565
+13% +$249K ﹤0.01% 2781
2018
Q2
$1.9M Sell
50,785
-890
-2% -$31K ﹤0.01% 2757
2018
Q1
$1.51M Hold
51,675
﹤0.01% 2801
2017
Q4
$1.93M Hold
51,675
﹤0.01% 2668
2017
Q3
$1.95M Hold
51,675
﹤0.01% 2628
2017
Q2
$1.39M Hold
51,675
﹤0.01% 2782
2017
Q1
$1.02M Sell
51,675
-7,000
-12% -$129K ﹤0.01% 2879
2016
Q4
$1.11M Hold
58,675
﹤0.01% 2921
2016
Q3
$956K Sell
58,675
-24,800
-30% -$389K ﹤0.01% 2929
2016
Q2
$1.14M Sell
83,475
-95,147
-53% -$1.34M ﹤0.01% 2820
2016
Q1
$2.78M Sell
178,622
-32,678
-15% -$479K ﹤0.01% 2335
2015
Q4
$3.39M Buy
211,300
+11,500
+6% +$175K ﹤0.01% 2298
2015
Q3
$2.39M Buy
199,800
+49,900
+33% +$663K ﹤0.01% 2519
2015
Q2
$2.13M Buy
149,900
+41,960
+39% +$595K ﹤0.01% 2715
2015
Q1
$1.55M Hold
107,940
﹤0.01% 2710
2014
Q4
$1.51M Hold
107,940
﹤0.01% 2675
2014
Q3
$1.4M Sell
107,940
-9,990
-8% -$137K ﹤0.01% 2646
2014
Q2
$1.65M Buy
117,930
+30
+0% +$451 ﹤0.01% 2598
2014
Q1
$1.96M Hold
117,900
﹤0.01% 2490
2013
Q4
$2.22M Sell
117,900
-612
-0.5% -$10.7K ﹤0.01% 2430
2013
Q3
$2.23M Hold
118,512
﹤0.01% 2385
2013
Q2
$2.13M Buy
+118,512
New +$1.89M ﹤0.01% 2339

Other funds holding NRC

Ameriprise's NRC Position: Q1 2026 in Review

Ameriprise reduced its NRC Health Common Stock (NRC) stake by 0.25% in Q1 2026, selling an estimated $1.77K and leaving 41,856 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #3438.

Ameriprise first reported a position in NRC in Q2 2013 and has held it in 51 quarters since. The position peaked at $20.9M in Q2 2019. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Ameriprise held 41,856 shares of NRC Health Common Stock worth $711K as of Q1 2026.
  • Ameriprise sold 104 NRC Health Common Stock shares in Q1 2026, an estimated $1.77K.
  • NRC Health Common Stock made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3438 holding.
  • Ameriprise first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 51 quarters since.
  • Ameriprise's NRC Health Common Stock position peaked at $20.9M in Q2 2019.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.